[1]GAZZANIGA P,GRADILONE A,DE BERARDINIS E,et al.Prognostic value of circulating tumor cells in nonmuscle invasive bladder cancer:a CellSearch analysis[J].Annals of oncology:official journal of the European Society for Medical Oncology,2012,23(9):2352-2356.
[2]GAZZANIGA P,DE BERARDINNIS E,RAIMONDI C,et al.Circulating tumor cells detection has independent prognostic impact in high-risk non-muscle invasive bladder cancer[J].International journal of cancer,2014,135(8):1978-1982.
[3]SOAVE A,RIETHDORF S,DAHLEM R,et al.Detection and oncological effect of circulating tumour cells in patients with variant urothelial carcinoma histology treated with radical cystectomy[J].BJU Int,2017,119(6):854-861.
[4]ALVA A,FRIEDLANDER T,CLARK M,et al.Circulating Tumor Cells as Potential Biomarkers in Bladder Cancer[J].J Urol,2015,194(3):790-798.
[5]OKEGAWA T,HAYASHI K,HARA H,et al.Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer[J].Int J Urol,2010,17(3):254-258.
[6]BIRKENKAMP-DEMTRODER K,NORDENTOFT I,CHRISTENSEN E,et al.Genomic alterations in liquid biopsies from patients with bladder cancer[J].Eur Urol,2016,70(1):75-82.
[7]CHRISTENSEN E,BIRKENKAMP-DEMTRODER K,NORDENTOFT I,et al.Liquid biopsy analysis of FGFR3 and PIK3CA hotspot mutations for disease surveillance in bladder cancer[J].Eur Urol,2017,71:961-969.
[8]BIRKENKAMP-DEMTRODER K,CHRISTENSEN E,NORDENTOFT I,et al.Monitoring treatment response and metastatic relapse in advanced bladder cancer by liquid biopsy analysis[J].Eur Urol,2017,73(4):535-540.
[9]PANTEL K.Blood-Based Analysis of Circulating Cell-Free DNA and T umor Cells for Early Cancer Detection[J].PLoS Med,2016,13:e1002205
[10]ADALSTEINSSON VA,HA G,FREEMAN SS,et al.Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors[J].Nat Commun,2017,8(1):1324.
[11]AGARWAL N,PAL S,HAHN A,et al.Characterization of metastatic urothelial carcinoma via comprehensive genomic profiling of circulating tumor DNA[J].Cancer,2018,124:2115-2124.
[12]MCGREGOR B,CHUNG J,BERGEROT P,et al.Correlation of circulating tumor DNA(ctDNA)ssessment with tissue-based comprehensive genomic profiling(CGP)in metastatic urothelial cancer(MUC)[J].J Clin Oncol,2018,36:453.
[13]BECKHAM C,OLSEN J,YIN P,et al.Bladder cancer exosomes contain EDIL-3/Del1 and facilitate cancer progression[J].J Urol,2014,192(2):583-592.
[14]LONG JD,SULLIVAN TB,HUMPHREY J,et al.A non invasive miRNA based assay to detect bladder cancer in cell-free urine[J].AmJ Transl Res,2015,7(11):2500-2509.
[15]BERRONDO C,FLAX J,KUCHEROV V,et al.Expression of the long non-coding RNA HOTAIR correlates with disease pro-gression in bladder cancer and is contained in bladder cancer patient urinary exosomes[J].PLoS One,2016,11(1):e0147236.